We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lilly Pulls Plug on All Tabalumab RA Trials, Citing Lack of Efficacy
Lilly Pulls Plug on All Tabalumab RA Trials, Citing Lack of Efficacy
February 7, 2013
Eli Lilly is pulling the plug on all its tabalumab studies in rheumatoid arthritis (RA) after another Phase III trial found the drug is ineffective.